Read the latest news from the world of Saltigo

2021-04-12

Be Safe When Outside: Avoid Tick & Mosquito Bites with Picaridin from LANXESS

  • Insect repellents with the active ingredient Picaridin (Saltidin®/ Icaridin) provide effective protection for the whole family
  • EPA registered and World Health Organization recommended

USA,US -

Pittsburgh, PA – April 20, 2021 – Life rarely throws one problem at a time at us … even during a global pandemic. In September 2020* the Centers for Disease Control and Prevention (CDC) identified reversing “the upward trends in illness, suffering, and death from vector-borne diseases” (those spread by insects) as a priority. The CDC also identifies Picaridin (also known as Saltidin®/Icaridin, produced by LANXESS) as “safe and effective” in preventing tick and mosquito bites.**

 

“Mosquitos that may carry the Zika virus, West Nile Virus or Dengue Fever and ticks that may spread Lyme disease can be found throughout the US,” advises Dr. Nora Hofmann, Global Business Manager Saltidin. “And,” she adds, “one need not to be deep in the forest or on tropical vacation to encounter them. Many people are bitten in their own backyards or during sports like golfing or hiking and could become infected with serious diseases. You should therefore urgently take care to treat parts of the body that are not covered by clothing with insect repellents and thus protect yourself from these diseases.”

 

What makes Picaridin so effective?

Developed in the 1990s and registered with the U.S. EPA since 2001, Picaridin interferes with insects’ ability to recognize humans as a source of blood. Picaridin products provide up to 14 hours of protection (depending on the formulation) and are safe for the whole family when used as directed. Currently, there are several major brands of Picaridin-based repellents available in the U.S. and throughout the world, in various concentrations and application methods, such as sprays, creams, wipes and sticks. 

 

Use with confidence on the whole family!

Picaridin is a highly effective, broad-spectrum insect repellent active ingredient that can be used with confidence on the whole family. Picaridin is appreciated for its skin-friendly properties. It is not oily, greasy or sticky on the skin. And, unlike other active ingredients, Picaridin does not damage plastics or other synthetic materials found on sports gear, bicycles, camping gear, fishing line and other outdoor equipment. 

 

“Picaridin/Saltidin® appeals to those who are concerned about the disadvantages associated with other insect repellent active ingredients,” says Christian Lewandowski,  Product Manager for Picaridin in the US and Canada. “As an active ingredient Picaridin offers formulators the perfect balance of effectiveness, safety and user-friendliness.”

 

Recommended and registered!

Picaridin is a CDC-recommended, EPA-registered insect repellent active ingredient found effective in providing long-lasting protection from mosquitoes, as well as ticks. Picaridin is also recommended by the World Health Organization.***

 

 

For more information, including repellent brands containing Picaridin (Saltidin®/Icaridin), visit www.picaridin.saltidin.com

 

Saltidin® is manufactured by LANXESS’ Saltigo business unit. Saltigo, a globally active company, is dedicated to custom synthesis and manufacturing services for small molecules. We serve globally the needs of customers in the Pharma, Agro, Specialty Chemical industries and Consumer Protection. Our business consists of over 85% Custom Manufacturing Services; less than 15 % are Fine Chemical Intermediates. We provide cost effective services when and where our customers need them by applying excellent project management skills.

 

LANXESS is a leading specialty chemicals company with sales of EUR 6.1 billion in 2020. The company currently has about 14,300 employees in 33 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

 

 

Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.

 

Information for editors:

All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

You can find further information concerning LANXESS chemistry in our WebMagazine at http://webmagazine.lanxess.com.

 

Follow us on Twitter, Facebook, Linkedin and YouTube:

 

http://www.twitter.com/LANXESS

http://www.facebook.com/LANXESS

http://www.linkedin.com/company/lanxess

http://www.youtube.com/lanxess

 

* ”A National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans.” Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)

** https://www.cdc.gov/ncezid/dvbd/about/prevent-bites.html

*** WHO refers to KBR3023.

Contact

Tim Gagne
Corporate Communications

Phone: +1 412-809-3723